ORAMED PHARMACEUTICALS INC.·4

Jan 8, 4:37 PM ET

Sank Leonard 4

4 · ORAMED PHARMACEUTICALS INC. · Filed Jan 8, 2024

Insider Transaction Report

Form 4
Period: 2024-01-04
Sank Leonard
Director
Transactions
  • Award

    Common Stock

    2024-01-04+30,00088,696 total
  • Award

    Common Stock

    2024-01-04+9,32598,021 total
Footnotes (2)
  • [F1]Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2025, January 1, 2026 and January 1, 2027. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
  • [F2]Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 2,331 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION